###
Authors of "Treatment outcomes from 68Ga PSMA PET-CT-informed salvage radiation treatment in men with rising PSA following radical prostatectomy: Prognostic value of a negative PSMA PET" include Louise Emmett, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, St. Vincent's Hospital, and University of New South Wales, Sydney, Australia; Pim J. van Leeuwen and Matthijs J. Scheltema, Australian Prostate Cancer Research Centre, New South Wales, Australia; Rohan Nandurkar, University of New South Wales; Thomas Cusick, Phillip Stricker and Quoc Nguyen, Australian Prostate Cancer Research Centre and Garvan Institute of Medical Research/The Kinghorn Cancer Centre; George Hruby, Andrew Kneebone and Thomas Eade, Royal North Shore Hospital and Genesis Cancer Care, Sydney, Australia; Gerald Fogarty and Raj Jagavkar, Genesis Cancer Care; Bao Ho, St. Vincent's Public Hospital; and Anthony M. Joshua, Garvan Institute of Medical Research/The Kinghorn Cancer Centre.
Ad Statistics
Times Displayed: 22201
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Please visit the SNMMI Media Center to view the PDF of the study, including images, and more information about molecular imaging and personalized medicine. To schedule an interview with the researchers, please contact Laurie Callahan at (703) 652-6773 or lcallahan@snmmi.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising awareness about nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI's more than 15,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice.
Back to HCB News
